These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18462099)

  • 1. Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment.
    Franke MF; Appleton SC; Bayona J; Arteaga F; Palacios E; Llaro K; Shin SS; Becerra MC; Murray MB; Mitnick CD
    Clin Infect Dis; 2008 Jun; 46(12):1844-51. PubMed ID: 18462099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K; Altraja A
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-resistant Mycobacterium tuberculosis: a report of cosmopolitan microbial migration and an analysis of best management practices.
    Joean O; Thiele T; Schütz K; Schwerk N; Sedlacek L; Kalsdorf B; Baumann U; Stoll M
    BMC Infect Dis; 2020 Sep; 20(1):678. PubMed ID: 32942990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India.
    Isaakidis P; Paryani R; Khan S; Mansoor H; Manglani M; Valiyakath A; Saranchuk P; Furin J
    PLoS One; 2013; 8(7):e68869. PubMed ID: 23894358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
    Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
    Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    Shibabaw A; Gelaw B; Wang SH; Tessema B
    PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
    Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania.
    Mpagama SG; Heysell SK; Ndusilo ND; Kumburu HH; Lekule IA; Kisonga RM; Gratz J; Boeree MJ; Houpt ER; Kibiki GS
    PLoS One; 2013; 8(5):e62034. PubMed ID: 23675411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
    Xu HB; Jiang RH; Li L; Xiao HP
    Int J Tuberc Lung Dis; 2012; 16(3):358-63. PubMed ID: 22640450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly successful treatment outcome of multidrug-resistant and genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains in Rwanda.
    Muvunyi CM; Ngabonziza JCS; Uwimana I; Harelimana JD; Mucyo Y; Sebatunzi OR; Muvunyi TZ; Seruyange E; Masaisa F; Mazarati JB; Gasana M
    Trop Med Int Health; 2019 Jul; 24(7):879-887. PubMed ID: 31066112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of risk factors associated with drug-resistant tuberculosis in Yemen: data from centres with high drug resistance.
    Jaber AAS; Ibrahim B
    BMC Infect Dis; 2019 May; 19(1):464. PubMed ID: 31126246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector.
    Jeon DS; Shin DO; Park SK; Seo JE; Seo HS; Cho YS; Lee JY; Kim DY; Kong SJ; Kim YS; Shim TS
    J Korean Med Sci; 2011 Jan; 26(1):33-41. PubMed ID: 21218027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of patient and program factors on default during treatment of multidrug-resistant tuberculosis.
    Gler MT; Podewils LJ; Munez N; Galipot M; Quelapio MI; Tupasi TE
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):955-60. PubMed ID: 22584124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol, hospital discharge, and socioeconomic risk factors for default from multidrug resistant tuberculosis treatment in rural South Africa: a retrospective cohort study.
    Kendall EA; Theron D; Franke MF; van Helden P; Victor TC; Murray MB; Warren RM; Jacobson KR
    PLoS One; 2013; 8(12):e83480. PubMed ID: 24349518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001.
    Holtz TH; Lancaster J; Laserson KF; Wells CD; Thorpe L; Weyer K
    Int J Tuberc Lung Dis; 2006 Jun; 10(6):649-55. PubMed ID: 16776452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to sputum culture conversion and its predictors among patients with multidrug-resistant tuberculosis in Hangzhou, China: A retrospective cohort study.
    Li Q; Lu M; Hsieh E; Wu L; Wu Y; Wang M; Wang L; Zhao G; Xie L; Qian HZ
    Medicine (Baltimore); 2020 Dec; 99(50):e23649. PubMed ID: 33327347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study.
    Javaid A; Ullah I; Masud H; Basit A; Ahmad W; Butt ZA; Qasim M
    Clin Microbiol Infect; 2018 Jun; 24(6):612-617. PubMed ID: 28970158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.